Recruiting studies: Neoadjuvant Immunochemotherapy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Sub-lobectomy vs Lobectomy in IIA-IIIB NSCLC After Neoadjuvant IO+Chemo
NA · 1 location(s) · Wen-zhao ZHONG · NCT07612722 Neoadjuvant Immunochemotherapy in Locally Advanced Esophagogastric Junction Adenocarcinoma
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT05170503 Neoadjuvant Immunochemotherapy for Locally Advanced Cervical Cancer: a Prospective, Single-arm, Phase II Clinical Trial
Phase 2 · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT07003620 Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal Carcinoma
Phase 3 · 1 location(s) · Henan Cancer Hospital · NCT04280822 Neoadjuvant Immunochemotherapy for LAOSCC
Phase 3 · 1 location(s) · Lai-ping Zhong · NCT06258811 Surufatinib in Combination With Neoadjuvant Chemo-immunotherapy and Concurrent Chemoradiotherapy for Patients With Unres
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT07086469 A Bidirectional Observational Clinical Study of NAIC in the Treatment of Tumor Regression Patterns in LA-OSCC and LA-OPS
Phase N/A · 1 location(s) · Zhujiang Hospital · NCT07133958 PD-1 Inhibitor Therapy Versus Radiotherapy in pCR Patients With Locally Advanced HNSCC After Neoadjuvant Immunochemother
Phase 3 · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT05980715 Low-dose Radiation Combined With Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma
Phase 2 · 1 location(s) · Sichuan University · NCT06446726 Safety and Efficacy of Neoadjuvant Immunochemotherapy in Elderly Patients With Resectable Esophageal Cancer
Phase 2 · 1 location(s) · Sichuan University · NCT06403878 Neoadjuvant Immunochemotherapy and Chemoradiotherapy Followed by Surgery for Advanced Esophageal Squamous Cell Carcinoma
Phase 2 · 1 location(s) · National Taiwan University Hospital · NCT06764355 Time-of-Day of Immunotherapy Infusion in Neoadjuvant Immunochemotherapy for Thoracic ESCC
Phase 2 · 1 location(s) · Tang-Du Hospital · NCT07452601 Hypofractionated Radiotherapy Plus Immunochemotherapy for Neoadjuvant Treatment of Gastroesophageal Junction Adenocarcin
Phase 1/Phase 2 · 4 location(s) · West China Hospital · NCT07182565 HDAC Inhibitor Combination With Chemoimmunotherapy in the Neoadjuvant Treatment of pMMR Locally Advanced Colon Cancer
Phase 2 · 1 location(s) · Daping Hospital and the Research Institute of Surgery of the · NCT06709885 Neoadjuvant Therapy of Sintilimab Combined With Chemotherapy for Resectable Squamous Cell NSCLC（neoSCORE Ⅱ）
Phase 3 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT05429463 Deep Learning Model Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma Following Neoadjuvant
Phase N/A · 1 location(s) · Tongji Hospital · NCT07088354 Phase II Open-label Trial of Neoadjuvant Immunochemotherapy for Resectable Non-metastatic Colon cancER: NICER
Phase 2 · 1 location(s) · Baylor College of Medicine · NCT05870800 PROPHET Study: ctDNA-Guided Personalized Induction Immunochemotherapy for NSCLC
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT06977074 PPIO-008 Tislelizumab Combined With S-1 in Patients With ypT+N0 ESCC After Radical Resection With Neoadjuvant STUDY
Phase 2 · 1 location(s) · Daping Hospital and the Research Institute of Surgery of the · NCT06354140 Minimally Residual of Esophageal Cancer 001
Phase N/A · 1 location(s) · Hebei Medical University Fourth Hospital · NCT05952661 Stereotactic Body Radiotherapy Followed by Tislelizumab Plus Platinum-based Chemotherapy Versus Tislelizumab Plus Platin
Phase 3 · 1 location(s) · Yang Hong · NCT06598527 Neoadjuvant Immunochemotherapy in PD-L1-negative LACC
Phase 2 · 12 location(s) · Tongji Hospital · NCT06288360 Tolecizumab Plus Chemoimmunotherapy for pMMR/MSS Locally Advanced Colon Adenocarcinoma
Phase 2 · 1 location(s) · Daping Hospital and the Research Institute of Surgery of the · NCT07468630

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.